Clinical Research Day 2025
Thursday, 6 February 2025
11.15 - 17.15
University Hospital Basel
Kleiner Hörsaal, Zentrum für Lehre und Forschung (ZLF)
Dear colleagues
Clinical research is constantly facing new challenges, especially in the development of innovative therapies for diseases that are not necessarily the focus of attention. These include, in particular, neglected diseases that affect millions of people worldwide.
For the scientific kick-off of this year's Clinical Research Day, we are delighted to welcome Prof. Jennifer Keiser. Prof Keiser is Head of the Helminth Drug Development Unit at the Swiss Tropical and Public Health Institute (Swiss TPH) and Professor of Neglected Tropical Diseases at the University of Basel. Her research focusses on the development of new drugs against parasitic worm infections, which affect over 1.5 billion people worldwide.
Prof Keiser has conducted phase 1-3 clinical trials in various endemic regions such as Côte d'Ivoire, Laos and Tanzania and has contributed significantly to the fight against these diseases through her international collaborations.
She will demonstrate how cutting-edge research is driving new therapeutic approaches and what challenges still exist to sustainably improve health in affected regions.
The subsequent scientific programme will focus on the department's young researchers, who will present their latest research work in oral, rapid-fire and poster presentations. A scientific jury will select the three best oral presenatations and the three best posters. The best rapid-fire presentation will be identified by public voting.
At the end, we will meet for an apero riche, the award ceremony and the opportunity for informal exchange and networking.
We are looking forward to a varied overview of current clinical research projects and an exciting and inspiring research day.
Christiane Pauli-Magnus and Niklaus Labhardt (Co-Directors, DKF)
Lars Hemkens (Senior Scientist, DKF)
Programm | |
---|---|
11.15 | Opening remarks Niklaus Labhardt and Christiane Pauli-Magnus (Leitung DKF) |
11.30 | Keynote lecture «New drugs for helminth infections» Prof. Jennifer Keiser, Head of Helminth Drug Development Unit, Swiss Tropical and Public Health Institute (Swiss TPH) |
12.15 | Session 1: Oral presentations The 6-months follow-up of the TREAT-CAD trial Hair salons as a promising space to provide HIV and sexual and reproductive health services for young women in Lesotho Serum glial fibrillary acidic protein (sGFAP) levels decrease under fingolimod treatment and prognosticate disease progression independent of relapse activity in multiple sclerosis Effect of adjunct oral betamethasone on time to clinical stabilisation and risk of rehospitalisation in children with community-acquired pneumonia admitted to Chairs: Annette Brühl (Center for Affective, Stress and Sleep Disorders, UPK), Elisabeth Kappos (Reconstructive surgery, USB), Yaldizli Özgür (Neurology, USB), Jehuda Soleman (Neurosurgery, UKBB) |
13.15 | Poster session & lunch |
14.15 | Session 2: Rapid fire presentations with public voting Retinal neuronal loss and Serum glial fibrillary acidic protein as additive markers of disability in Multiple Sclerosis Effects of JAK inhibitors in adults hospitalized due to COVID-19 Defining the need for analgesia in the emergency department: an international Delphi Process Non-pharmacological Interventions for Psychological Distress in Patients with Cancer and their Family Caregivers Kangaroo Care to reduce mortality, sepsis and invasive infection in low-birthweight infants Exenatide-Test for diagnosing endogenous hyperinsulinemic hypoglycaemia a randomized placebo-controlled cross-over proof-of-principle study FAST Study Effectiveness of Blended Learning to Improve Medical Students Communication Skills Food-induced Cortisol Drives Energy in Adipose Tissue Acute effects and pharmacokinetics of LSD after paroxetine or placebo pretreatment in a randomized, double-blind, cross-over trial in healthy participants Aspirin in Surgically Treated Chronic Subdural Hematoma Moderation: B. Kasenda |
15.15 | Poster session & coffee break |
15.45 | Session 3: Oral presentations Single-dose versus 3-day antimicrobial prophylaxis in transurethral resection or photoselective vaporization of the prostate Long-Term Outcomes of Patients Requiring Pacemaker Implantation after Transcatheter Aortic Valve Implantation Intraoperative Ultrasound-Guided compared to Stereotactically-Navigated Ventriculoperitoneal Shunt Placement Targeted correction of plasma sodium in hospitalized patients with - HIT Studie Endovascular Treatment for Medium or Distal Vessel Occlusion Stroke Chairs: Miriam Christ-Crain (Endocrinology, diabetes and metabolism, USB), Alexander Datta (Neuro- and Developmental Pediatrics, UKBB), Mira Katan Kahles (Neurology, USB), Christian Müller (Cardiovascular Research Institute Basel CRIB, USB) |
17.00 | HEMMI Research Prize 2025 |
17.10 | Closing remarks |
17.30 | Apéro Riche Location: Centrino |